Upgrade to SI Premium - Free Trial

Niagen Bioscience (NAGE)

2.96 -0.08 (2.63%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/4/26)

Latest Headlines

Niagen Bioscience to Present at Canaccord Genuity’s Well Summit September 10, 2026 8:32 AM - BizWire Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit August 26, 2026 8:32 AM - BizWire Canaccord Reiterates Buy Rating on Niagen Bioscience (NAGE) August 24, 2026 6:41 AM - StreetInsider Niagen Bioscience's Tru Niagen now sold at GNC and Sam's Club August 20, 2026 8:32 AM - StreetInsider Niagen Bioscience Expands Tru Niagen® Retail Footprint with GNC and Sam’s Club August 20, 2026 8:32 AM - BizWire Niagen Bioscience to Present at the 17th Annual Midwest IDEAS Investor Conference August 12, 2026 8:32 AM - BizWire Niagen Bioscience lists Tru Niagen supplement on Walmart.com August 6, 2026 8:34 AM - StreetInsider Niagen Bioscience Launches Tru Niagen on Walmart.com, Expanding Access and Diversifying Its E-commerce Marketplace Presence August 6, 2026 8:34 AM - BizWire Niagen Bioscience, Inc. (NAGE) Misses Q2 EPS by 1c August 4, 2026 5:31 PM - StreetInsider Form 10-Q Niagen Bioscience, Inc. For: Jun 30 August 4, 2026 4:05 PM - SEC Filing Form 8-K Niagen Bioscience, Inc. For: Aug 04 August 4, 2026 4:04 PM - SEC Filing Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results August 4, 2026 4:02 PM - BizWire Niagen Bioscience taps Evotec for NB4168 preclinical drug studies August 3, 2026 8:33 AM - StreetInsider Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168 August 3, 2026 8:32 AM - BizWire Form SCHEDULE 13G Niagen Bioscience, Inc. Filed by: BlackRock, Inc. July 29, 2026 3:22 PM - SEC Filing study links NR supplement to reduced muscle epigenetic aging marker July 28, 2026 8:32 AM - StreetInsider Niagen Bioscience Announces a Newly Published Analysis of Past Clinical Studies Demonstrating Niagen® (Patented Nicotinamide Riboside, NR) Supplementation Improved a Muscle-Specific Marker of Biologi July 28, 2026 8:32 AM - BizWire Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference July 27, 2026 8:32 AM - BizWire Niagen Bioscience to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026 July 21, 2026 8:32 AM - BizWire Niagen Bioscience names new senior director of global research July 16, 2026 8:32 AM - StreetInsider Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research July 16, 2026 8:32 AM - BizWire Niagen Bioscience wins FDA and EMA designations for A-T drug July 13, 2026 8:32 AM - StreetInsider Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia July 13, 2026 8:32 AM - BizWire Niagen Bioscience files to sell up to $50M in common stock July 10, 2026 5:08 PM - StreetInsider Form 424B5 Niagen Bioscience, Inc. July 10, 2026 5:06 PM - SEC Filing Canaccord Reiterates Buy Rating on Niagen Bioscience (NAGE) July 10, 2026 6:55 AM - StreetInsider Form EFFECT Niagen Bioscience, Inc. July 10, 2026 6:04 AM - SEC Filing Niagen Bioscience CEO Rob Fried to Participate in Virtual Fireside Chat to Discuss Pharmaceutical Strategy on July 15, 2026 July 9, 2026 8:32 AM - BizWire H.C. Wainwright Reiterates Buy Rating on Niagen Bioscience (NAGE) July 9, 2026 6:52 AM - StreetInsider Form 4 Niagen Bioscience, Inc. For: Jun 30 Filed by: Lopez Carlos Luis July 8, 2026 5:19 PM - SEC Filing Form 4 Niagen Bioscience, Inc. For: Jun 30 Filed by: Pamir Ozan July 8, 2026 5:18 PM - SEC Filing Form 4 Niagen Bioscience, Inc. For: Jun 30 Filed by: Fried Robert N July 8, 2026 5:17 PM - SEC Filing Niagen Bioscience launches drug candidate for rare genetic disease July 8, 2026 8:33 AM - StreetInsider Niagen Bioscience Launches Pharmaceutical Program for Accelerated Aging and Rare Genetic Diseases July 8, 2026 8:32 AM - BizWire Freedom Broker Starts Niagen Bioscience (NAGE) at Buy July 6, 2026 3:03 PM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Niagen Bioscience (NAGE) July 1, 2026 7:04 AM - StreetInsider Form 8-K Niagen Bioscience, Inc. For: Jun 24 June 29, 2026 4:31 PM - SEC Filing Niagen Bioscience (NAGE) files $125M mixed shelf June 29, 2026 6:06 AM - StreetInsider Form S-3 Niagen Bioscience, Inc. June 29, 2026 6:03 AM - SEC Filing Form 4 Niagen Bioscience, Inc. For: Jun 24 Filed by: YU Wing Tak Wendy June 26, 2026 6:03 PM - SEC Filing Form 4 Niagen Bioscience, Inc. For: Jun 24 Filed by: Ng Wang Yu Gary June 26, 2026 6:02 PM - SEC Filing Form 4 Niagen Bioscience, Inc. For: Jun 24 Filed by: Cohen Ann June 26, 2026 6:01 PM - SEC Filing Form 4 Niagen Bioscience, Inc. For: Jun 24 Filed by: Patrick Kristin June 26, 2026 5:58 PM - SEC Filing Form 4 Niagen Bioscience, Inc. For: Jun 24 Filed by: Shahbazi Hamed June 26, 2026 5:57 PM - SEC Filing Form 4 Niagen Bioscience, Inc. For: Jun 24 Filed by: Rubin Steven D June 26, 2026 5:56 PM - SEC Filing Form 4 Niagen Bioscience, Inc. For: Jun 24 Filed by: Jaksch Frank L Jr June 26, 2026 5:55 PM - SEC Filing Full Article List